|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
US20080113025A1
(en)
*
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
|
CA2348871C
(en)
|
1998-11-02 |
2009-04-14 |
John G. Devane |
Multiparticulate modified release composition
|
|
US20080102121A1
(en)
*
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
AU2001257315A1
(en)
*
|
2000-04-26 |
2001-11-20 |
Elan Pharma International, Ltd. |
Apparatus for sanitary wet milling
|
|
DE60105023T2
(de)
*
|
2000-06-28 |
2005-08-18 |
Smithkline Beecham P.L.C., Brentford |
Nassvermahlungsverfahren
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
JP2005504266A
(ja)
*
|
2001-06-22 |
2005-02-10 |
エラン ファーマ インターナショナル，リミティド |
小規模ミルまたは微小流体工学を用いる高スループットスクリーニング法
|
|
US20030152519A1
(en)
*
|
2001-11-07 |
2003-08-14 |
Reinhard Koenig |
Methods for vascular imaging using nanoparticulate contrast agents
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
DE60332212D1
(de)
*
|
2002-02-04 |
2010-06-02 |
Elan Pharma Int Ltd |
Arzneistoffnanopartikel mit lysozym-oberflächenstabilisator
|
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
JP4865990B2
(ja)
|
2002-04-12 |
2012-02-01 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子メゲストロール製剤
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
EP1511467A1
(en)
*
|
2002-06-10 |
2005-03-09 |
Elan Pharma International Limited |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
AU2003261167A1
(en)
*
|
2002-07-16 |
2004-02-02 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
WO2005000265A2
(en)
*
|
2002-09-11 |
2005-01-06 |
Elan Pharma International Ltd. |
Gel-stabilized nanoparticulate active agent compositions
|
|
EP1556091A1
(en)
*
|
2002-10-04 |
2005-07-27 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
WO2004045585A1
(en)
*
|
2002-11-18 |
2004-06-03 |
E.I. Du Pont De Nemours And Company |
Media milling using nonspherical grinding media
|
|
AU2003297151A1
(en)
*
|
2002-12-17 |
2004-07-22 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
JP4469846B2
(ja)
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子状トピラメート製剤
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20100297252A1
(en)
*
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
EP1626742A1
(en)
*
|
2003-05-22 |
2006-02-22 |
Elan Pharma International Limited |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
ITMI20031037A1
(it)
*
|
2003-05-23 |
2004-11-24 |
Gamma Croma Spa |
Metodo e apparecchiatura per lo stampaggio di un prodotto cosmetico.
|
|
DE10335552B4
(de)
*
|
2003-08-02 |
2005-07-28 |
Stephan Machinery Gmbh & Co. |
Mischwelle zur Durchmischung und Zerteilung von Lebensmittelprodukten sowie Verfahren zur Herstellung eines Überzugs für eine derartige Mischwelle
|
|
WO2005016310A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
EA200701065A1
(ru)
*
|
2004-11-16 |
2007-12-28 |
Элан Фарма Интернэшнл Лтд. |
Инъецируемые составы, содержащие нанодисперсный оланзапин
|
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
KR20070116581A
(ko)
*
|
2004-12-15 |
2007-12-10 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 타크롤리무스 제제
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
EA200701442A1
(ru)
*
|
2005-01-06 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиции наночастиц кандесартана
|
|
MX2007009915A
(es)
*
|
2005-02-15 |
2007-11-06 |
Elan Pharma Int Ltd |
Formulaciones en aerosol e inyectables de benzodiazepina nanoparticulada.
|
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
EA200701987A1
(ru)
*
|
2005-03-16 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Составы из нанодисперсного антагониста лейкотриеновых рецепторов/кортикостероида
|
|
EP1865928A1
(en)
*
|
2005-03-17 |
2007-12-19 |
Elan Pharma International Limited |
Nanoparticulate biphosphonate compositions
|
|
WO2006102494A2
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
CN101171000A
(zh)
|
2005-04-12 |
2008-04-30 |
依兰药物国际有限公司 |
包含环孢菌素的毫微粒和控制释放组合物
|
|
US20070029252A1
(en)
*
|
2005-04-12 |
2007-02-08 |
Dunson James B Jr |
System and process for biomass treatment
|
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
BRPI0612944B1
(pt)
*
|
2005-04-12 |
2017-11-28 |
E.I.Du Pont De Nemours And Company |
Method of production of target substance
|
|
JP2008535924A
(ja)
*
|
2005-04-12 |
2008-09-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子キナゾリン誘導体製剤
|
|
JP2008540546A
(ja)
*
|
2005-05-10 |
2008-11-20 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クロピドグレル製剤
|
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
|
EP1901728A2
(en)
*
|
2005-06-03 |
2008-03-26 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
|
DE602006012671D1
(de)
*
|
2005-06-03 |
2010-04-15 |
Elan Pharma Int Ltd |
Nanoteilchenförmige imatinib-mesylat-formulierungen
|
|
EP1954253A4
(en)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
|
|
ES2335608T3
(es)
*
|
2005-06-09 |
2010-03-30 |
Elan Pharma International Limited |
Formulaciones de ebistina nanoparticuladas.
|
|
AU2006259606A1
(en)
*
|
2005-06-13 |
2006-12-28 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
|
EP1931340A2
(en)
*
|
2005-06-15 |
2008-06-18 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
|
CA2614412A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
JP2009507925A
(ja)
*
|
2005-09-13 |
2009-02-26 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子タダラフィル製剤
|
|
EP1933814A2
(en)
*
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
|
UA96936C2
(uk)
|
2005-12-29 |
2011-12-26 |
Лексикон Фармасьютикалз, Инк. |
Поліциклічні похідні амінокислот і їх застосування
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
|
SG174054A1
(en)
|
2006-05-04 |
2011-09-29 |
Boehringer Ingelheim Int |
Polymorphs
|
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
|
MX2008015275A
(es)
*
|
2006-05-30 |
2009-02-06 |
Elan Pharma Int Ltd |
Formulaciones de posaconazol en nanoparticulas.
|
|
US20080213374A1
(en)
*
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
WO2008008879A2
(en)
*
|
2006-07-12 |
2008-01-17 |
Elan Corporation, Plc |
Nanoparticulate formulations of modafinil
|
|
TWI318894B
(en)
*
|
2006-08-07 |
2010-01-01 |
Ind Tech Res Inst |
System for fabricating nano particles
|
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
|
US20080259722A1
(en)
*
|
2007-04-23 |
2008-10-23 |
Sanford Samuel A |
Blender for production of scented materials
|
|
US7441717B1
(en)
*
|
2007-10-31 |
2008-10-28 |
Eastman Kodak Company |
Micromedia milling process
|
|
KR20110007095A
(ko)
*
|
2008-03-21 |
2011-01-21 |
엘란 파마 인터내셔널 리미티드 |
이마티니브의 부위-특이적 전달을 위한 조성물 및 사용방법
|
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
|
RU2531305C2
(ru)
*
|
2008-12-26 |
2014-10-20 |
Асахи Гласс Компани, Лимитед |
Способ гранулирования сополимера этилен/тетрафторэтилен
|
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
|
DE102009019868B4
(de)
*
|
2009-05-06 |
2015-10-22 |
Hosokawa Alpine Ag |
Verfahrenstechnische Anlage für den Laborbetrieb
|
|
DE102009019869B4
(de)
|
2009-05-06 |
2012-09-06 |
Hosokawa Alpine Ag |
Gehäuse für verfahrenstechnische Maschinen und Apparate
|
|
DE202009006458U1
(de)
|
2009-05-06 |
2010-09-23 |
Hosokawa Alpine Ag |
Gehäuse für verfahrenstechnische Maschinen und Apparate
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
|
CN102711749A
(zh)
|
2009-11-05 |
2012-10-03 |
莱西肯医药有限公司 |
用于癌症治疗的色氨酸羟化酶抑制剂
|
|
EP3646859A1
(en)
|
2009-11-27 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
|
|
US20130137635A1
(en)
|
2010-02-10 |
2013-05-30 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
|
|
NZ602921A
(en)
|
2010-05-05 |
2016-01-29 |
Boehringer Ingelheim Int |
Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
|
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
|
US10717960B2
(en)
|
2011-10-10 |
2020-07-21 |
Dasgip Information And Technology Gmbh |
Biotechnological apparatus comprising a bioreactor, exhaust gas temperature control device for a bioreactor and a method for treating an exhaust gas stream in a biotechnological apparatus
|
|
WO2013148978A1
(en)
|
2012-03-30 |
2013-10-03 |
Lexicon Pharmaceuticals, Inc. |
Methods and compositions for the treatment of necrotizing enterocolitis
|
|
EP4151218A1
(en)
|
2012-05-14 |
2023-03-22 |
Boehringer Ingelheim International GmbH |
Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
|
|
US20130303462A1
(en)
|
2012-05-14 |
2013-11-14 |
Boehringer Ingelheim International Gmbh |
Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
|
|
BR112015020572B1
(pt)
|
2013-02-28 |
2022-02-22 |
Sun Chemical Corporation |
Processo contínuo para transformar sólido moído em dispersão líquida e aparelho
|
|
US9410630B1
(en)
*
|
2013-05-06 |
2016-08-09 |
Taylor Innovations Llc |
Sealing member for use in non-simmering clean service relief valve
|
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
|
DE102015105804A1
(de)
*
|
2015-04-16 |
2016-10-20 |
Netzsch-Feinmahltechnik Gmbh |
Rührwerkskugelmühle
|
|
US9844558B1
(en)
|
2015-04-30 |
2017-12-19 |
Amag Pharmaceuticals, Inc. |
Methods of reducing risk of preterm birth
|
|
EP3288957A4
(en)
|
2015-05-01 |
2019-01-23 |
Cocrystal Pharma, Inc. |
NUCLEOSIDE ANALOGUE FOR THE TREATMENT OF VIRUSES OF THE FLAVIVIIDAE FAMILY AND CANCER
|
|
US10556922B2
(en)
|
2015-09-29 |
2020-02-11 |
Amag Pharmaceuticals, Inc. |
Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate
|
|
EP3468562A1
(en)
|
2016-06-10 |
2019-04-17 |
Boehringer Ingelheim International GmbH |
Combinations of linagliptin and metformin
|
|
EP3732180A4
(en)
|
2017-12-27 |
2022-05-11 |
Emory University |
COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRALS
|
|
ES2824761T3
(es)
*
|
2018-05-25 |
2021-05-13 |
Buehler Ag |
Dispositivo de distribución-dosificación para un molino de cilindros, molino de cilindros con un dispositivo de distribución-dosificación de este tipo y procedimiento para moler material a moler
|
|
AU2020289560A1
(en)
|
2019-06-05 |
2021-12-23 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
|
CN113828395B
(zh)
*
|
2021-09-03 |
2023-01-31 |
南京利卡维智能科技有限公司 |
一种多轴研磨机
|
|
MX2024010565A
(es)
|
2022-03-02 |
2024-09-06 |
Horizon Therapeutics Ireland Dac |
Procedimiento de fabricacion de un antagonista cristalino del receptor edg-2.
|